RA Capital Management, L.P. 13D/13G Filings for TScan Therapeutics, Inc. (TCRX)

RA Capital Management, L.P. 13D and 13G filings for TScan Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-08-15
5:10 pm
Sale		 2022-08-15 13G TScan Therapeutics, Inc.
TCRX		 RA Capital Management, L.P. 0
0.000%		 -1,255,317decrease
(Position Closed)		 Filing
2021-07-28
4:30 pm
Purchase		 2021-07-20 13G TScan Therapeutics, Inc.
TCRX		 RA Capital Management, L.P. 1,255,317
6.700%		 1,255,317increase
(New Position)		 Filing